| Founder |
|
|---|---|
| Headquarters |
Vancouver, British Columbia , Canada |
Key people |
|
Number of employees | 15 FTE (2015) |
| Website |
www |
| Footnotes / references [1] [2] | |
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. [1] The company focuses on development of cell therapies using a patient's own cells ( autologous cell therapy). [1] The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, [3] and hair restoration. [2] The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle. [1]
The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. [2] An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. [1]
- ^ a b c d e Dutton, Gail (15 April 2015). "Cell Therapy Is "Hair Raising" in a Good Way". Genetic Engineering & Biotechnology News. 35 (8): 8–9. Retrieved 16 July 2016.
- ^ a b c Ellis, Erin (30 October 2013). "A cure for baldness? Stem cell researchers race to regenerate follicles from hair resistant to loss". National Post. Toronto. Retrieved 2016-07-15.
- ^ Ilic, Dusko (September 2013). "Industry Update: Latest developments in stem cell research and regenerative medicine". Regenerative Medicine. 8 (5). RepliCel. doi: 10.2217/rme.13.56.
 | This article about a Canadian corporation or company is a stub. You can help Wikipedia by expanding it. |
| Founder |
|
|---|---|
| Headquarters |
Vancouver, British Columbia , Canada |
Key people |
|
Number of employees | 15 FTE (2015) |
| Website |
www |
| Footnotes / references [1] [2] | |
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. [1] The company focuses on development of cell therapies using a patient's own cells ( autologous cell therapy). [1] The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, [3] and hair restoration. [2] The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle. [1]
The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. [2] An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. [1]
- ^ a b c d e Dutton, Gail (15 April 2015). "Cell Therapy Is "Hair Raising" in a Good Way". Genetic Engineering & Biotechnology News. 35 (8): 8–9. Retrieved 16 July 2016.
- ^ a b c Ellis, Erin (30 October 2013). "A cure for baldness? Stem cell researchers race to regenerate follicles from hair resistant to loss". National Post. Toronto. Retrieved 2016-07-15.
- ^ Ilic, Dusko (September 2013). "Industry Update: Latest developments in stem cell research and regenerative medicine". Regenerative Medicine. 8 (5). RepliCel. doi: 10.2217/rme.13.56.
|
| This article about a Canadian corporation or company is a stub. You can help Wikipedia by expanding it. |